
Reply To: Caseous Lymphadenitis (CL)
From Merck, of particular note is the Treatment and Control section:
“Recent studies have shown that administration of one dose of tulathromycin at 2.5 mg/kg, either SC directly into the abscess cavity, or two doses at 2.5 mg/kg, administered at the same time, one SC and one intralesionally, can resolve the lesions without lancing the abscess. Further, effective concentrations of tulathromycin can be achieved within walled-off abscesses caused by C pseudotuberculosis after a single dose at 2.5 mg/kg, SC. The highly lipid-soluble property of tulathromycin may be particularly helpful in cases of internal CL, when abscesses are not accessible for other forms of treatment. Despite the efficacy of intralesional and parenteral administration of tulathromycin in many cases, recurrence remains a problem. Therefore, use of these drugs cannot be considered curative but rather an acceptable alternative to manage cases of CL when culling from the herd or flock is not an acceptable option for the owner.”
merckvetmanual.com
Caseous Lymphadenitis of Sheep and Goats - Circulatory System - Merck Veterinary Manual
Learn about the veterinary topic of Caseous Lymphadenitis of Sheep and Goats. Find specific details on this topic and related topics from the Merck Vet Manual.